Open Payments

Ascension St John Hospital

Type
Teaching hospital
Where
Chicago, IL
Medicare CCN
230165
Received
$289,502 in 45 records, 2025 ($24,420 general, $265,082 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2025General payment16$24,420
2025Research payment29$265,082

By company

CompanyRecordsAmountYears
AstraZeneca Pharmaceuticals LP1$120,0062025
PFIZER INC.11$94,2702025
Medtronic, Inc.14$20,0892025
Genentech, Inc.1$19,0762025
BeOne Medicines USA, Inc.1$8,7502025
Parkedale Pharmaceuticals, Inc.5$4,9602025
ABBVIE INC.2$4,0002025
Olympus Corporation of the Americas1$4,0002025
Takeda Pharmaceuticals U.S.A., Inc.2$4,0002025
ERBE USA Inc1$2,0002025
GENZYME CORPORATION1$2,0002025
Gilead Sciences, Inc.1$2,0002025
Olympus America Inc.2$2,0002025
Siemens Medical Solutions USA, Inc.1$1,8002025
Abbott Laboratories1$5502025

By nature of payment

NatureRecordsAmount
Research payment29$265,082
Space rental or facility fees (teaching hospital only)9$14,550
Grant1$4,000
Education1$2,000
Debt forgiveness1$1,800
Consulting Fee3$1,075
Royalty or License1$995

Records

DateCompanyAmountNatureFormProductStudyYear
2025-12-11PFIZER INC.$6,846Research paymentCash or cash equivalentA PHASE 12 RANDOMIZED OBSERVERBLIND STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCI2025
2025-12-11Medtronic, Inc.$831Research paymentCash or cash equivalentCOREVALVE EVOLUT R Device, Transcatheter Valve SystemsSMART Trial2025
2025-12-11Medtronic, Inc.$831Research paymentCash or cash equivalentCOREVALVE EVOLUT R Device, Transcatheter Valve SystemsSMART Trial2025
2025-12-09BeOne Medicines USA, Inc.$8,750Research paymentCash or cash equivalentBRUKINSA Drug, OncologyA Phase 3 Randomized, Open-Label Multicenter Study of Zanubrutinib (BGB-3111) Plus Anti-CD20 Antibodies Versus Lenalidom2025
2025-11-26PFIZER INC.$3,876Research paymentCash or cash equivalentA PHASE 12 RANDOMIZED OBSERVERBLIND STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCI2025
2025-11-03Parkedale Pharmaceuticals, Inc.$350Consulting FeeCash or cash equivalentBICILLIN CR Drug, INFECTIOUS DISEASES2025
2025-10-27Parkedale Pharmaceuticals, Inc.$605Consulting FeeCash or cash equivalentBICILLIN CR Drug, INFECTIOUS DISEASES2025
2025-10-14Parkedale Pharmaceuticals, Inc.$120Consulting FeeCash or cash equivalentBICILLIN CR Drug, INFECTIOUS DISEASES2025
2025-09-29Parkedale Pharmaceuticals, Inc.$2,890Research paymentCash or cash equivalentBICILLIN CR Drug, INFECTIOUS DISEASESPRE CLINICAL2025
2025-09-03Medtronic, Inc.$2,491Research paymentCash or cash equivalentCOREVALVE EVOLUT R Device, Transcatheter Valve SystemsSMART Trial2025
2025-09-03Medtronic, Inc.$2,491Research paymentCash or cash equivalentCOREVALVE EVOLUT R Device, Transcatheter Valve SystemsSMART Trial2025
2025-08-25Parkedale Pharmaceuticals, Inc.$995Royalty or LicenseCash or cash equivalentBICILLIN CR Drug, INFECTIOUS DISEASES2025
2025-06-26PFIZER INC.$9,994Research paymentCash or cash equivalentA PHASE 12 RANDOMIZED OBSERVERBLIND STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCI2025
2025-06-23Medtronic, Inc.$4,192Research paymentCash or cash equivalentSYMPLICITY G3 Device, Renal Denervation SystemSPYRAL AFFIRM2025
2025-06-05Medtronic, Inc.$745Research paymentCash or cash equivalentCOREVALVE EVOLUT R Device, Transcatheter Valve SystemsSMART Trial2025
2025-06-05Medtronic, Inc.$745Research paymentCash or cash equivalentCOREVALVE EVOLUT R Device, Transcatheter Valve SystemsSMART Trial2025
2025-05-28PFIZER INC.$565Research paymentCash or cash equivalentAN INTERVENTIONAL PHASE 23 ADAPTIVE MULTICENTER RANDOMIZED DOUBLEBLIND STUDY TO INVESTIGATE EFFICACY AND SAFETY OF ORAL 2025
2025-05-21AstraZeneca Pharmaceuticals LP$120,006Research paymentCash or cash equivalentTruqap Drug, OncologyCapivasertib plus Palbociclib plus Fulvestrant for HR/HER2 Advanced Breast Cancer CAPItello 292.2025
2025-05-16Medtronic, Inc.$89Research paymentIn-kind items and servicesSYMPLICITY G3 Device, Renal Denervation SystemSPYRAL AFFIRM2025
2025-05-14PFIZER INC.$565Research paymentCash or cash equivalentAN INTERVENTIONAL PHASE 23 ADAPTIVE MULTICENTER RANDOMIZED DOUBLEBLIND STUDY TO INVESTIGATE EFFICACY AND SAFETY OF ORAL 2025
2025-05-10PFIZER INC.$17,462Research paymentCash or cash equivalentPREVNAR 20 Biological, VACCINESA PHASE 4 STUDY USING A TESTNEGATIVE DESIGN TO EVALUATE THE EFFECTIVENESS OF A 20VALENT PNEUMOCOCCAL CONJUGATE VACCINE A2025
2025-04-25PFIZER INC.$2,175Research paymentCash or cash equivalentAN INTERVENTIONAL PHASE 23 ADAPTIVE MULTICENTER RANDOMIZED DOUBLEBLIND STUDY TO INVESTIGATE EFFICACY AND SAFETY OF ORAL 2025
2025-04-24Medtronic, Inc.$1,067Research paymentCash or cash equivalentCOREVALVE EVOLUT R Device, Transcatheter Valve SystemsTAVR Low Risk2025
2025-04-24Medtronic, Inc.$1,067Research paymentCash or cash equivalentCOREVALVE EVOLUT R Device, Transcatheter Valve SystemsTAVR Low Risk2025
2025-04-23Medtronic, Inc.$180Research paymentCash or cash equivalentCOREVALVE EVOLUT R Device, Transcatheter Valve SystemsCoreValve SURTAVI2025
2025-04-23Medtronic, Inc.$180Research paymentCash or cash equivalentCOREVALVE EVOLUT R Device, Transcatheter Valve SystemsCoreValve SURTAVI2025
2025-04-14Olympus Corporation of the Americas$4,000GrantCash or cash equivalent2025
2025-04-12GENZYME CORPORATION$2,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentDUPIXENT Biological, Immunology2025
2025-04-12ERBE USA Inc$2,000EducationCash or cash equivalentErbe VIO3, Erbe Jet Device, gastroenterology2025
2025-04-02Takeda Pharmaceuticals U.S.A., Inc.$2,000Space rental or facility fees (teaching hospital only)Cash or cash equivalent2025
2025-04-01Olympus America Inc.$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentSingle Use Repositionable Clip Device, Endotherapy2025
2025-04-01Olympus America Inc.$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentSingle Use Repositionable Clip Device, Endotherapy2025
2025-03-29PFIZER INC.$10,487Research paymentCash or cash equivalentPREVNAR 20 Biological, VACCINESA PHASE 4 STUDY USING A TESTNEGATIVE DESIGN TO EVALUATE THE EFFECTIVENESS OF A 20VALENT PNEUMOCOCCAL CONJUGATE VACCINE A2025
2025-03-28ABBVIE INC.$2,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentSKYRIZI Biological, IMMUNOLOGY2025
2025-03-28Abbott Laboratories$550Space rental or facility fees (teaching hospital only)Cash or cash equivalent2025
2025-03-25ABBVIE INC.$2,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentCREON Drug, ENDOCRINOLOGY2025
2025-03-24Genentech, Inc.$19,076Research paymentCash or cash equivalentActemra Biological, ImmunologyPhase 3 randomized mosunetuzumab with polatuzumab in comparison with R GemOx in R R NHL2025
2025-03-20Medtronic, Inc.$3,429Research paymentCash or cash equivalentSYMPLICITY G3 Device, Renal Denervation SystemSPYRAL AFFIRM2025
2025-03-12Gilead Sciences, Inc.$2,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentEpclusa Drug, HCV2025
2025-03-04PFIZER INC.$15,933Research paymentCash or cash equivalentPREVNAR 20 Biological, VACCINESA PHASE 4 STUDY USING A TESTNEGATIVE DESIGN TO EVALUATE THE EFFECTIVENESS OF A 20VALENT PNEUMOCOCCAL CONJUGATE VACCINE A2025
2025-02-21Takeda Pharmaceuticals U.S.A., Inc.$2,000Space rental or facility fees (teaching hospital only)Cash or cash equivalent2025
2025-02-06PFIZER INC.$9,070Research paymentCash or cash equivalentPREVNAR 20 Biological, VACCINESA PHASE 4 STUDY USING A TESTNEGATIVE DESIGN TO EVALUATE THE EFFECTIVENESS OF A 20VALENT PNEUMOCOCCAL CONJUGATE VACCINE A2025
2025-01-28PFIZER INC.$17,292Research paymentCash or cash equivalentPREVNAR 20 Biological, VACCINESA PHASE 4 STUDY USING A TESTNEGATIVE DESIGN TO EVALUATE THE EFFECTIVENESS OF A 20VALENT PNEUMOCOCCAL CONJUGATE VACCINE A2025
2025-01-27Medtronic, Inc.$1,750Research paymentCash or cash equivalentCOREVALVE EVOLUT R Device, Transcatheter Valve SystemsOptimize Pro2025
2025-01-10Siemens Medical Solutions USA, Inc.$1,800Debt forgivenessCash or cash equivalent2025

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Cook CountyChicago city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Chicago, IL, county Cook County, IL, state Illinois; placed by its city name.

MeasurePlace (city or town)
Chicago, IL
County
Cook County, IL
State
Illinois
Population B010032,711,2265,182,09012,694,798
Population, 2020 census P12,746,3885,275,54112,812,508
Median age B0100235.838.039.0
Under 18 B0100119.4%21.1%21.8%
65 and over B0100113.8%16.0%17.0%
Households B110011,160,2052,100,2305,036,449
Foreign born B0500220.9%21.7%14.7%
Median household income B19013$77,902$83,498$83,390
Median family income B19113$95,774$104,836$106,018
Per capita income B19301$50,086$49,329$46,406
Poverty rate B1700116.8%13.5%11.8%
Unemployment rate B230258.0%7.0%5.8%
Civilian labor force B230251,517,3302,792,8886,652,134
Mean commute (minutes) B0801333.131.527.8
Bachelor's degree or higher B1500344.3%42.7%37.8%
Housing units B250011,277,0542,276,4935,457,452
Owner-occupied B2500346.0%57.7%67.1%
Renters B2500354.0%42.3%32.9%
Median home value B25077$334,100$324,500$263,300
Median gross rent B25064$1,440$1,435$1,274
White, not Hispanic B0300232.1%40.1%58.1%
Black B0300227.4%21.8%13.3%
Hispanic or Latino B0300229.7%26.8%18.8%
Asian B030027.2%7.9%5.9%
American Indian and Alaska Native B030020.1%0.1%0.1%

Economy now FRED unemployment 4.6% in Sep 2026 (4.5% a year earlier); per capita personal income $78,987 in 2025, up 28% in five years (+3.1% after inflation); Unemployment rate: 5.7% in Sep 2016 to 4.6% in Sep 2026; low 3.6%, high 18.3% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Chicago, IL.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.